Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03522779 · ClinicalTrials.gov registry record · NA

Antioxidant Responses to Exercise and Cherry Consumption

A NA study, sponsored by University of Georgia.

Completed
Registry status
NA
Development phase
13
Enrollment target

NCT03522779: Completed NA study, sponsored by University of Georgia.

NCT03522779 is a NA study that has completed, run by University of Georgia. The registered enrollment target is 13 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03522779, a NA study, has completed, sponsored by University of Georgia.

COMPLETED
Registry status
NA
Development phase
13 participants
Enrollment target

Study Summary

To date, there are no published studies on the effects of tart cherry consumption on postprandial antioxidant and oxidative stress levels following a high-fat meal. Further, no one has looked at the effects of prior exercise on a high-fat meal that includes high phytonutrients like tart cherries. Therefore, the purpose of this study is to examine the effects of tart cherry consumption on antioxidant and oxidative stress levels in human plasma after consumption of a high-fat meal, as well as the postprandial impact of prior exercise in combination with tart cherry consumption on a high-fat meal.

Primary Outcome

Plasma will be tested for total anthocyanins content by HPLC-UV/VIS as well as HPLC-ESI-MS. Antioxidant capacity measurements will be performed by FRAP assays.

Interventions

  • OTHER Exercise
  • OTHER High-fat meal
  • DIETARY_SUPPLEMENT Tart cherry Juice

Trial Details

FieldValue
Enrollment Target 13 participants
Start Date 2016-11
Est. Completion 2017-07-01
Phase NA
University of Georgia

59 total trials

What the finished NCT03522779 record still lists

NCT03522779 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 3 interventions - of which Exercise is the first listed.

NCT03522779 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03522779 about?

NCT03522779 is a clinical study titled "Antioxidant Responses to Exercise and Cherry Consumption". To date, there are no published studies on the effects of tart cherry consumption on postprandial antioxidant and oxidative stress levels following a high-fat meal. Further, no one has looked at the effects of prior exercise on a high-fat meal that includes high phytonutrients like tart cherries. Th...

What is the current status of trial NCT03522779?

This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2016-11. Estimated completion is 2017-07-01.

What interventions are being tested in trial NCT03522779?

The interventions under investigation include: Exercise (OTHER), High-fat meal (OTHER), Tart cherry Juice (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT03522779?

This trial is sponsored by University of Georgia, which has 59 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03522779's enrollment target sits among peer trials

13 1911th of 2000 higher than 88 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03125655 · 13 participants

    Regulation of Inflammatory Genes in Psoriasis

  • NCT03774446 · 13 participants · Phase 2

    Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease

  • NCT03830151 · 13 participants · Phase 1

    Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors

  • NCT04573231 · 13 participants · Phase 2

    Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT03522779, the US trial registry maintained by the National Library of Medicine. NCT03522779 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.